Advancing drug development innovation through “Imprinted genes + AI” convergence, Lisen Imprinting and Galixir signs a deepening cooperation agreement

Lisen's QCIGISH Technology Published in Journal

Lisen's collaborative research work on the development and application of the QCIGISH technology in the early detection of ten cancer types gets published in the Clinical Epigenetics journal.

Lisen Recognized Among Best Healthcare Startups by Merck

Lisen's innovative technology was recognized as one of the top six best Asian healthcare startups by Merck in its 2019 Accelerator Program in China.